The pharmacological basis of anti-IgE therapy

Article Abstract:

Unique, humanized anti-IgE monoclonal antibodies are found to be useful in the treatment of asthma and allergic rhinitis according to the results of multiple phase II and III human clinical studies.

Taiwan, Antiasthmatic Preparations, Antiasthmatic agents

---

CD18 trials disappoint again

Article Abstract:

Genentech's anti-CD18 monoclonal antibodies, designed for use in treating heart attacks, perform poorly in a phase II trial, failing to improve blood flow within the 90 minute target range.

Cardiovascular Preparations, Genentech Inc., Cardiovascular agents, GNE

---

Growing pains for biopharmaceuticals. Biopharmaceuticals have provided a swift means of swelling pharmaceutical company pipelines, but they may not be such a fast "fix" for the industry in the future

Article Abstract:

This study examines the economic contribution of biotechnology (recombinant proteins, and monoclonal antibodies) and its impact upon drug development, and the pharmaceutical industry as a whole for the years 1982 through 2000.

Research and Development in the Physical, Engineering, and Life Sciences, Market information - general, Genetic Engineering, Pharmaceutical Preparations, Drugs

Similar abstracts:

• Abstracts: Tumor angiogenesis-new drugs on the block: angeogenisis inhibitors could represent adjunct to traditional cancer treatments, but the most effective routes for therapeutic intervention remain unclear
• Abstracts: Super-wide-format inkjet printers offer consistency plus versatility. Microsoft's new Windows Me is game for the joystick

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.